Spaceflight bone loss is the reduction in bone mass and bone mineral density that astronauts experience during exposure to microgravity, which one review puts at 1 to 2% bone loss per month.1

That review describes how ground-based simulations of microgravity are used to study the process, and reports that their observations are largely congruent with data from spaceflight experiments while adding information on molecular mechanisms. This supports using simulations to study mechanism, but the review does not make a simulation equivalent to flight.1

A second review states that bone mineral density loss over a stay on the International Space Station is on average similar to the loss between the fifth and sixth decade of life on Earth. This is a comparison of averages, and the sources used here do not give rates for each skeletal site or each individual.2

NASA states that after return to Earth the bone loss might not be completely corrected by rehabilitation, and that fracture risk is not higher. It also reports that bisphosphonate medications have been shown in NASA studies to be effective in preventing bone loss; the page is a summary for the public and does not give the trial evidence behind that statement.3

Footnotes

  1. npj Microgravity, “The effects of microgravity on bone structure and function”. https://www.nature.com/articles/s41526-022-00194-8 ↩ ↩2

  2. Frontiers in Physiology, “Human Pathophysiological Adaptations to the Space Environment”. https://www.frontiersin.org/articles/10.3389/fphys.2017.00547/full ↩

  3. NASA, “The Human Body in Space”. https://www.nasa.gov/hrp/bodyinspace ↩